SynthesisFrontiers in endocrinology2025

The efficacy and safety of danuglipron and orforglipron in patients with type 2 diabetes and obesity: a systematic review and meta-analysis.

Jingjing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.